ArticleJournal of clinical medicine2020

Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab.

Guillaume Herbreteau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.